Recruiting

NM90Neuralli Mood Supplement Impact on Stress, Sleep, Mood and Burnout

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to evaluate the impact of Neuralli Mood Supplement on your stress levels and sleep quality, by measuring changes in the Depression Anxiety and Stress Scales-21 Stress Subscale Score and the PROMIS Sleep Disturbance Score.

What is being tested

Neuralli Mood

Dietary Supplement
Who is being recruted

Occupational Stress+10

+ Behavior

+ Mental Disorders

Over 18 Years
+15 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other Study

Interventional
Study Start: June 2026
See protocol details

Summary

Principal SponsorEfforia, Inc
Study ContactMatthew AmsdenMore contacts
Last updated: July 21, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: June 30, 2026

Actual date on which the first participant was enrolled.

Neuralli Mood is a probiotic and postbiotic dietary supplement containing the proprietary gut-brain strains L. plantarum PS128 and heat-treated L. paracasei PS23. Participants take two capsules once daily, with or without food, at a consistent time for 90 days. Each two-capsule daily dose contains 30 billion CFU of L. plantarum PS128 and 20 billion heat-treated cells of L. paracasei PS23. The study uses a prospective, open-label, single-group, within-participant design. Participants complete baseline assessments before the first dose and repeat the primary and secondary outcome assessments at the end of the 90-day supplementation period. Scheduled check-ins are used to assess adherence, tolerability, and adverse events. The study is exploratory and is intended to generate preliminary evidence and individualized before-and-after information. Results will be interpreted in light of the absence of a concurrent control group, participant self-selection, expectation effects, and reliance on self-reported outcomes.

NCT07717385
Principal SponsorEfforia, Inc
Study ContactMatthew AmsdenMore contacts
Last updated: July 21, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

100 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other Study

Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Occupational StressBehaviorMental DisordersBehavioral SymptomsNervous System DiseasesOccupational DiseasesSleep Wake DisordersBurnout, PsychologicalAnxiety DisordersBurnout, ProfessionalDepressionStress, PsychologicalParasomnias

Criteria

5 inclusion criteria required to participate
Has reliable access to the internet and an email-enabled device
Willing and able to take two capsules of Neuralli Mood daily for 90 days
Age 18 years or older and able to provide informed consent
Willing and able to complete electronic baseline, follow-up, adherence, and safety assessments
Show More Criteria
10 exclusion criteria prevent from participating
Known allergy or hypersensitivity to Neuralli Mood, probiotics, or any product ingredient
A clinically significant sleep disorder for which participation or changes in symptoms should be managed by a healthcare professional
Immunocompromised status or current immunosuppressive therapy
Severe or unstable gastrointestinal disease, including a condition for which probiotic use may be inappropriate
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Participants take two capsules of Neuralli Mood once daily, with or without food, at a consistent time for 90 days and complete scheduled study assessments and safety check-ins.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Efforia - Decentralized United States Study

New York, United StatesOpen Efforia - Decentralized United States Study in Google Maps
Recruiting
One Study Center